Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:55 AM
Ignite Modification Date:
2025-12-25 @ 3:55 AM
NCT ID:
NCT00198302
Eligibility Criteria:
Inclusion Criteria:
* Male or female, age ≥ 18 years old
* Informed consent obtained from subject or legal guardian
* Willing to practice reliable birth control measures during the study period
* Diagnosis of SAB, as evidenced by clinical symptoms and one positive blood culture obtained ≤ 72 hours prior to initiation of study drug infusion
Exclusion Criteria:
* Pregnant or nursing females
* Polymicrobial bacteremia
* Diagnosis of septic shock (refer to APPENDIX B)
* Neutropenia (absolute neutrophil count \< 500/mm³)
* Undergoing any type of dialysis or expected to start dialysis within 30 days
* Moribund clinical condition with a high likelihood of death within 72 hours of randomization
* Received an investigational drug within 30 days of study entry
* Considered unlikely to comply with the study procedures or to return for scheduled post-treatment evaluations
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00198302
Study Brief:
Protocol Section:
NCT00198302